E.g., 06/28/2022
E.g., 06/28/2022
Title Category Credit Event date Price
Update Series Volume 41 (2022) $480.00 For the most timely topics and latest surgical techniques in urology, you won't want to miss the 2022 AUA Update Series—AUA's most popular self-study CME product.Concise, practical lessons on timely topics including state-of-the-art surgical techniquesAuthors and Editors are among the best in their specialties
Urologic Care for the Advanced Practice Provider Webcast (2020) $0.00 COMPLIMENTARY WEBCAST FOR AUA MEMBERS!
Webcast: Global Advancements in Prostate Cancer: Best Practices in Hormonal Therapy (2022) - English
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Global Advancements in Prostate Cancer: Best Practices in Hormonal Therapy (2022) is an exciting new global educational initiative featuring a Moderator and two other subject matter experts in an interactive, interview-style presentation and discussion.  
Webcast: Global Advancements in Prostate Cancer: The Role of Genetic Testing & PARP Inhibitors (2022) - English
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00
What's New in the Management of Hormone Naïve & Castrate Resistant Prostate Cancer: A Case-based Session for Urologists, Advanced Practice...
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 This course will include case-based presentations and ARS in three distinct diseases groups: hormone-sensitive metastatic prostate cancer (HSMPC); non-metastatic castrate resistant prostate cancer (M0CRPC) and metastatic CRPC (MCRPC) to educate urologists, APP's and their teams to identify and understand  the many new FDA-approved agents, as well as existing standard therapies. Particular attention will be devoted to sequencing the new agents and positioning them as compared to older existing therapies. The cost effectiveness of new and existing agents will also be addressed.

Pages